CS

Chirag Shantilal Patel

Active Director Director DIN 10228213
DIN 10228213 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Chirag Shantilal Patel

Data last updated:

Chirag Shantilal Patel is a Director at Cormind Pharma Private Limited (since 2023). Cormind Pharma Private Limited reported revenue of ₹4.9 Lakh (FY 2025).

DIN 10228213
Primary Designation Director
First Appointment 06 Jul 2023
Oldest Company Age 3 yrs
Largest company Cormind Pharma Private Limited · ₹4.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cormind Pharma Private Limited U46497GJ2023PTC142678
Director06 Jul 20232023₹4.9 Lakh (FY 2025)Active

Board colleagues of Chirag Shantilal Patel

Directorship timeline

Open interactive timeline →
Cormind Pharma Private Limited
Premium access

Shareholding and investment profile for Chirag Shantilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Shantilal Patel

Chirag Shantilal Patel currently holds 1 directorship: Cormind Pharma Private Limited (Director, since 06 Jul 2023, revenue ₹4.9 Lakh (FY 2025)).

Chirag Shantilal Patel was first appointed on 06 Jul 2023 as Director at Cormind Pharma Private Limited.

The current boards of Chirag Shantilal Patel's companies include Ashish Ravindranath Sharma (Cormind Pharma Private Limited), Nikunjkumar Davabhai Patel (Cormind Pharma Private Limited), Ronak Rakeshkumar Shah (Cormind Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available